# Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

> **NCT06414460** · PHASE1 · RECRUITING · sponsor: **InSilico Medicine Hong Kong Limited** · enrollment: 80 (estimated)

## Conditions studied

- Locally Advanced/Metastatic Solid Tumors

## Interventions

- **DRUG:** ISM3412

## Key facts

- **NCT ID:** NCT06414460
- **Lead sponsor:** InSilico Medicine Hong Kong Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2028-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414460, "Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06414460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*